Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-88.13%
↓ 27% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
-69.42%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -88.13% | +18.7% |
| 2025 | -108.35% | +29.9% |
| 2024 | -154.52% | +0.9% |
| 2023 | -155.90% | -12.7% |
| 2022 | -138.36% | -28.8% |
| 2021 | -107.39% | -246.2% |
| 2020 | -31.02% | -259.2% |
| 2019 | 19.49% | -55.7% |
| 2018 | 43.97% | +69.0% |
| 2017 | 26.02% | - |